WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Mark Identification

Proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

We do not have any records of a proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV at this moment.

Click here to add a proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Possible trademark infringements of BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Basic Information about BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Serial Number
97715586
Filing Date
13 Dec 2022
Mark Drawing Code
3

Classifications

Declare the trademark use of BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV on the blockchain with WikiTrademarks.io.

First use of BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
005; 006; 018; 044; 046; 051; 052

Who owns BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV?

1. TG THERAPEUTICS, INC. New York NY

2. TG THERAPEUTICS, INC. New York NY

Correspondent

Maury M. Tepper, III TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH, NC 27609
United States

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV